bluebird bio Inc (BLUE)
7.65
-0.78
(-9.25%)
USD |
NASDAQ |
Dec 23, 13:34
bluebird bio Profit Margin (Quarterly): -573.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 37.71% |
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -245.9% |
| Return on Assets | -50.94% |
| Return on Invested Capital | -181.9% |
| Gross Profit Margin (Quarterly) | -11.02% |
| Operating Margin (Quarterly) | -604.1% |
| Return on Net Operating Assets | -83.21% |